Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Family Medicine's Contribution to the HIV Workforce.

Egan K, Jetty A, Petterson S, Liaw W, Wingrove PM, Bazemore A.

Fam Med. 2019 Jun;51(6):532-534. doi: 10.22454/FamMed.2019.918847. No abstract available.

2.

Primary Care Physician Characteristics Associated with Low Value Care Spending.

Barreto TW, Chung Y, Wingrove P, Young RA, Petterson S, Bazemore A, Liaw W.

J Am Board Fam Med. 2019 Mar-Apr;32(2):218-225. doi: 10.3122/jabfm.2019.02.180111.

3.

Characteristics of Young Family Physician Hospitalists.

Kamerow DB, Wingrove P, Petterson S, Peterson L, Bazemore A.

J Am Board Fam Med. 2018 Sep-Oct;31(5):680-681. doi: 10.3122/jabfm.2018.05.180070.

4.

The Growing Trend of Health Coaches in Team-Based Primary Care Training A Multicenter Pilot Study.

Gastala NM, Wingrove PM, Gaglioti AH, Liaw W, Bazemore A.

Fam Med. 2018 Jul;50(7):526-530. doi: 10.22454/FamMed.2018.459897.

5.

Predictors of Attrition From Family Medicine Board Certification.

Liaw W, Wingrove P, Petterson S, Peterson L, Park B, Bazemore A, Puffer JC.

Ann Fam Med. 2018 Jan;16(1):55-58. doi: 10.1370/afm.2176.

6.

Using Drug Prescribing Patterns to Identify Stewards of Cost-Conscious Care.

Gastala NM, Wingrove P, Liaw W, Petterson S, Bazemore A.

J Am Board Fam Med. 2017 Nov-Dec;30(6):824-827. doi: 10.3122/jabfm.2017.06.170019.

7.

Mobility of US Rural Primary Care Physicians During 2000-2014.

McGrail MR, Wingrove PM, Petterson SM, Bazemore AW.

Ann Fam Med. 2017 Jul;15(4):322-328. doi: 10.1370/afm.2096.

8.

Funding Instability Reduces the Impact of the Federal Teaching Health Center Graduate Medical Education Program.

Kurz T, Liaw W, Wingrove P, Petterson S, Bazemore A.

J Am Board Fam Med. 2017 May-Jun;30(3):279-280. doi: 10.3122/jabfm.2017.03.160341.

9.

Measuring the attractiveness of rural communities in accounting for differences of rural primary care workforce supply.

McGrail MR, Wingrove PM, Petterson SM, Humphreys JS, Russell DJ, Bazemore AW.

Rural Remote Health. 2017 Apr-Jun;17(2):3925. doi: 10.22605/RRH3925. Epub 2017 Apr 28.

10.

Regional Variation in Primary Care Involvement at the End of Life.

Ankuda CK, Petterson SM, Wingrove P, Bazemore AW.

Ann Fam Med. 2017 Jan;15(1):63-67. doi: 10.1370/afm.2002. Epub 2017 Jan 6.

11.

The Effects of Training Institution Practice Costs, Quality, and Other Characteristics on Future Practice.

Phillips RL Jr, Petterson SM, Bazemore AW, Wingrove P, Puffer JC.

Ann Fam Med. 2017 Mar;15(2):140-148. doi: 10.1370/afm.2044.

12.

Changes in Primary Care Graduate Medical Education Are Not Correlated With Indicators of Need: Are States Missing an Opportunity to Strengthen Their Primary Care Workforce?

Coutinho AJ, Klink K, Wingrove P, Petterson S, Phillips RL Jr, Bazemore A.

Acad Med. 2017 Sep;92(9):1280-1286. doi: 10.1097/ACM.0000000000001539.

PMID:
28030420
13.

Rural Opioid Use Disorder Treatment Depends on Family Physicians.

Wingrove P, Park B, Bazemore A.

Am Fam Physician. 2016 Oct 1;94(7):546. No abstract available.

14.

You can't treat what you don't diagnose: An analysis of the recognition of somatic presentations of depression and anxiety in primary care.

Gates K, Petterson S, Wingrove P, Miller B, Klink K.

Fam Syst Health. 2016 Dec;34(4):317-329. Epub 2016 Sep 5.

PMID:
27598458
15.

Office Visits for Women Aged 45-64 Years According to Physician Specialties.

Raffoul MC, Petterson SM, Rayburn WF, Wingrove P, Bazemore AW.

J Womens Health (Larchmt). 2016 Dec;25(12):1231-1236. Epub 2016 Sep 1.

PMID:
27585369
16.

Family Medicine: An Underutilized Resource in Addressing the Opioid Epidemic?

Crothers J, Petterson S, Bazemore A, Wingrove P.

Am Fam Physician. 2016 Sep 1;94(5):350. No abstract available.

17.

Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.

Gastala NM, Wingrove P, Gaglioti A, Petterson S, Bazemore A.

Health Aff (Millwood). 2016 Jul 1;35(7):1237-40. doi: 10.1377/hlthaff.2016.0146.

PMID:
27385239
18.

Over Half of Graduating Family Medicine Residents Report More Than $150,000 in Educational Debt.

Bazemore A, Peterson L, Jetty A, Wingrove P, Petterson S, Phillips R.

J Am Board Fam Med. 2016 Mar-Apr;29(2):180-1. doi: 10.3122/jabfm.2016.02.150247.

19.

The Diversity of Providers on the Family Medicine Team.

Bazemore A, Wingrove P, Peterson L, Petterson S.

J Am Board Fam Med. 2016 Jan-Feb;29(1):8-9. doi: 10.3122/jabfm.2016.01.150229.

20.

Graduates of Teaching Health Centers Are More Likely to Enter Practice in the Primary Care Safety Net.

Bazemore A, Wingrove P, Petterson S, Peterson L, Raffoul M, Phillips RL Jr.

Am Fam Physician. 2015 Nov 15;92(10):868. No abstract available.

21.

Family Physicians Contribute Significantly to Emergency Care of Medicare Patients in Urban and Suburban Areas.

Banks G, Wingrove P, Petterson SM, Klink K.

Am Fam Physician. 2015 Sep 15;92(6):445. No abstract available.

22.

Shifting sources of U.S. Primary care physicians.

Lin SX, Klink K, Wingrove P, Petterson S, Bazemore A.

Am Fam Physician. 2015 Jun 1;91(11):758. No abstract available.

23.

A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-D-aspartate type 2B receptor.

Rosahl TW, Wingrove PB, Hunt V, Fradley RL, Lawrence JM, Heavens RP, Treacey P, Usala M, Macaulay A, Bonnert TP, Whiting PJ, Wafford KA.

Mol Cell Neurosci. 2006 Sep;33(1):47-56. Epub 2006 Jul 25.

PMID:
16870468
24.

Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.

Thompson SA, Wheat L, Brown NA, Wingrove PB, Pillai GV, Whiting PJ, Adkins C, Woodward CH, Smith AJ, Simpson PB, Collins I, Wafford KA.

Br J Pharmacol. 2004 May;142(1):97-106. Epub 2004 Apr 20.

25.

Pharmacology of GABA(A) receptors exhibiting different levels of spontaneous activity.

Mortensen M, Wafford KA, Wingrove P, Ebert B.

Eur J Pharmacol. 2003 Aug 22;476(1-2):17-24.

PMID:
12969744
26.

Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors.

Thompson SA, Wingrove PB, Connelly L, Whiting PJ, Wafford KA.

Mol Pharmacol. 2002 Apr;61(4):861-9.

PMID:
11901225
27.

Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors.

Wingrove PB, Safo P, Wheat L, Thompson SA, Wafford KA, Whiting PJ.

Eur J Pharmacol. 2002 Feb 15;437(1-2):31-9.

PMID:
11864636
28.

Role of the histidine residue at position 105 in the human alpha 5 containing GABA(A) receptor on the affinity and efficacy of benzodiazepine site ligands.

Kelly MD, Smith A, Banks G, Wingrove P, Whiting PW, Atack J, Seabrook GR, Maubach KA.

Br J Pharmacol. 2002 Jan;135(1):248-56.

29.

The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors.

Wilkie N, Wingrove PB, Bilsland JG, Young L, Harper SJ, Hefti F, Ellis S, Pollack SJ.

J Neurochem. 2001 Sep;78(5):1135-45.

30.

Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.

Casula MA, Bromidge FA, Pillai GV, Wingrove PB, Martin K, Maubach K, Seabrook GR, Whiting PJ, Hadingham KL.

J Neurochem. 2001 Apr;77(2):445-51.

31.
32.

Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation.

Thompson SA, Smith MZ, Wingrove PB, Whiting PJ, Wafford KA.

Br J Pharmacol. 1999 Jul;127(6):1349-58.

33.

Residues in transmembrane domains I and II determine gamma-aminobutyric acid type AA receptor subtype-selective antagonism by furosemide.

Thompson SA, Arden SA, Marshall G, Wingrove PB, Whiting PJ, Wafford KA.

Mol Pharmacol. 1999 Jun;55(6):993-9.

PMID:
10347239
34.
35.

Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.

Grimwood S, Le Bourdell├Ęs B, Atack JR, Barton C, Cockett W, Cook SM, Gilbert E, Hutson PH, McKernan RM, Myers J, Ragan CI, Wingrove PB, Whiting PJ.

J Neurochem. 1996 Jun;66(6):2239-47.

PMID:
8632144
36.
37.
38.

A novel allosteric modulatory site on the GABAA receptor beta subunit.

Wafford KA, Bain CJ, Quirk K, McKernan RM, Wingrove PB, Whiting PJ, Kemp JA.

Neuron. 1994 Apr;12(4):775-82.

PMID:
8161449
39.

Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors.

Hadingham KL, Wingrove PB, Wafford KA, Bain C, Kemp JA, Palmer KJ, Wilson AW, Wilcox AS, Sikela JM, Ragan CI, et al.

Mol Pharmacol. 1993 Dec;44(6):1211-8. Erratum in: Mol Pharmacol 1994 Jul;46(1):211.

PMID:
8264558
41.

FISH ordering of reference markers and of the gene for the alpha 5 subunit of the gamma-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions.

Knoll JH, Sinnett D, Wagstaff J, Glatt K, Wilcox AS, Whiting PM, Wingrove P, Sikela JM, Lalande M.

Hum Mol Genet. 1993 Feb;2(2):183-9.

PMID:
8388764
42.

Cloning and expression of a cDNA encoding the human GABA-A receptor alpha 5 subunit.

Wingrove P, Hadingham K, Wafford K, Kemp JA, Ragan CI, Whiting P.

Biochem Soc Trans. 1992 Feb;20(1):18S. No abstract available.

PMID:
1321750

Supplemental Content

Loading ...
Support Center